Germany approves GNA Biosolutions' rapid test for emergency use German molecular diagnostics startup GNA Biosolutions said its quick Covid-19 test, which returns results in about 40 minutes, was approved for emergency use in Germany. The GNA Octea SARS-CoV-2 test system is based on pulse controlled amplification (PCA) technology and has a detection...
Read Full Story
Trending News
Trending News